Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study

---

Lang G. E. , Berta A., Eldem B. M. , Simader C., Sharp D., Holz F. G. , ...More

OPHTHALMOLOGY, vol.120, no.10, pp.2004-2012, 2013 (Journal Indexed in SCI)

• Publication Type: Article / Article
• Volume: 120 Issue: 10
• Publication Date: 2013
• Doi Number: 10.1016/j.ophtha.2013.02.019
• Title of Journal : OPHTHALMOLOGY
• Page Numbers: pp.2004-2012

Abstract

Objective: To evaluate the 2-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema (DME).